Sennagood (Tablets) Instructions for Use

Marketing Authorization Holder

Avva Rus, JSC (Russia)

ATC Code

A06AB06 (Sennosides A and B)

Active Substance

Sennosides A and B (Grouping name)

Dosage Form

Sennagood

Tablets 13.5 mg: 10, 20, 40, 60, 100, or 500 pcs.

Dosage Form, Packaging, and Composition

Tablets are round, biconvex, light brown to dark brown in color with inclusions.

Excipients: lactose monohydrate – 91 mg, croscarmellose sodium – 7.2 mg, corn starch – 6 mg, talc – 6 mg, colloidal silicon dioxide – 5 mg, magnesium stearate – 2 mg, microcrystalline cellulose – to make a tablet with a mass of 200 mg.

10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (2) – cardboard packs.
10 pcs. – blister packs (4) – cardboard packs.
10 pcs. – blister packs (6) – cardboard packs.
10 pcs. – blister packs (10) – cardboard packs.
10 pcs. – blister packs (50) – cardboard packs.

Clinical-Pharmacological Group

Laxative drug that stimulates intestinal peristalsis

Pharmacotherapeutic Group

Laxative of plant origin

Pharmacological Action

A laxative of plant origin. It has a laxative effect that occurs after 8-10 hours.

The laxative effect is due to the effect on the receptors of the large intestine, enhancing peristalsis.

Indications

Constipation caused by hypotension and sluggish peristalsis of the large intestine; regulation of stool in hemorrhoids, proctitis, anal fissures.

ICD codes

Dosage Regimen

Administer orally, typically as a single daily dose in the evening before bedtime.

For adults and children over 12 years, the standard dose is one to two tablets (13.5 mg to 27 mg of sennosides A and B).

For children aged 6 to 12 years, the recommended dose is half to one tablet (6.75 mg to 13.5 mg of sennosides A and B).

Adjust the initial dose to the lowest effective amount to produce a soft stool.

Do not exceed the maximum daily dose of four tablets (54 mg of sennosides A and B).

Swallow the tablets whole with a sufficient amount of water.

The laxative effect usually occurs within 8 to 12 hours after administration.

Limit the duration of use to a maximum of one to two weeks unless directed by a physician.

For long-term management of constipation, prioritize dietary and lifestyle measures such as increased fluid and fiber intake.

Discontinue use if abdominal pain, diarrhea, or other adverse reactions occur and consult a healthcare professional.

Adverse Reactions

From the digestive system: cramping abdominal pain, flatulence are possible; with long-term use, especially in high doses, melanin deposition in the intestinal mucosa, nausea, vomiting, diarrhea are possible.

From the metabolism: with long-term use, especially in high doses, disturbances in water-electrolyte balance, melanin deposition in the intestinal mucosa are possible.

From the urinary system: with long-term use, especially in high doses, albuminuria, hematuria, discoloration of urine are possible.

From the nervous system: with long-term use, especially in high doses, convulsions, fatigue, confusion are possible.

Dermatological reactions: with long-term use, especially in high doses, skin rash is possible.

From the cardiovascular system: with long-term use, especially in high doses, vascular collapse is possible.

Contraindications

Hypersensitivity to the active substance, spastic constipation, intestinal obstruction, abdominal pain of unclear origin, strangulated hernia, acute inflammatory diseases of the abdominal cavity, peritonitis, gastrointestinal and uterine bleeding, cystitis, disturbances of water-electrolyte balance; children under 6 years of age.

With caution

Liver and/or kidney diseases, pregnancy, breastfeeding period, conditions after abdominal surgery.

Use in Pregnancy and Lactation

Use with caution during pregnancy and breastfeeding.

Use in Hepatic Impairment

Use with caution in liver diseases.

Use in Renal Impairment

Use with caution in kidney diseases.

Pediatric Use

Contraindicated for use in children under 6 years of age.

Geriatric Use

The drug is approved for use in elderly patients.

Special Precautions

It is not recommended to use this remedy for more than 2 weeks.

After administration, urine may turn yellow-brown or red-lilac in color.

Drug Interactions

With long-term use in high doses, it is possible to enhance the effect of cardiac glycosides and influence the effect of antiarrhythmic drugs due to the possibility of developing hypokalemia.

With simultaneous use with thiazide diuretics, corticosteroids, licorice root preparations, the risk of developing hypokalemia increases.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.